ClinicalTrials.gg
RecruitingNCT05943652Updated Sep 29, 2025

Observational Study on "Functional Overlay" in Patients With Movement Disorders

An observational study in Conversion Disorder, Parkinson Disease and Tremor, sponsored by Medical University of Graz. Recruiting at 1 site in Austria. Open to participants aged 18 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-09-29.

Sponsored by Medical University of Graz · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2023; still recruiting 3 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
216
Ages
18 Years to 18 Years
Sex
All
01

Study summary

The goal of this observational study is to learn about functional neurological disorders in patients with common non-functional movement disorders ("functional overlay"). The main questions it aims to answer are:

  • What is the frequency of functional neurological disorders in patients with non-functional movement disorders (functional overlay)?
  • What are the characteristics of functional neurological disorders in patients with non-functional movement disorders?

Participants will be examined clinically and electrophysiologically, the examinations consist of:

  • a neurological examination
  • neuropsychological testing
  • electrophysiological tremor diagnostic
  • questionnaires about psychological, biological and social risk factors

Researchers will compare patients with functional motor disorders to patients wit non-functional movement disorders to see if they differ from each other regarding the functional symptoms.

Read the detailed description

Functional neurological disorders (FND) are common neurological disorders that are present in up to 16% of patients in neurological outpatient clinics. They are associated with a significant reduction in quality of life, can lead to permanent impairment, and have a poor prognosis, especially if the diagnosis is delayed.

FND have multifactorial causes and risk factors, including psychological stressors, childhood trauma, female gender, psychiatric disorders such as depression, anxiety disorder, or post-traumatic stress disorder, and other functional disorders such as irritable bowel syndrome or chronic pain syndrome. Patients with FND often report additional cognitive complaints ("cognitive fog").

A mismatch of various regulatory mechanisms, a disruption of sensory processing and motor output is assumed to be a central part of the pathogenesis. A characteristic feature of FND is a variability of symptoms according to attention. FND can be intensified by increased attention and weakened by distraction. Positive diagnostic criteria for FND have been established recently, so that by definition FND are no longer a diagnosis of exclusion.

The clinical presentations of FND are diverse and include impaired limb movement control, disturbances in vigilance that may be associated with seizures, and non-motor symptoms. FND often coincide and often coexist with pain, fatigue, sleep disorders, and cognitive disorders. Particularly non-motor functional symptoms are highly debilitating for patients.

The coincidence of "organic" neurological disorders and FND in the same patients ("functional overlay") is probably not uncommon, but has been investigated primarily in patients with Parkinson's Disease and epilepsy, so far. However, it is important to recognize FND in patients with movement disorders in order to treat them adequately and to protect them from incorrect treatment (surgery, unnecessary medication, etc.). However, the basic prerequisite for this is an exploration of the frequency and characteristics of the functional symptoms in movement disorders.

02

Conditions studied

  • Conversion Disorder
  • Parkinson Disease
  • Tremor
  • Dystonia

Keywords

  • Accelerometry
  • Patient Health Questionnaire
  • Neuropsychology
03

In context

Conversion Disorder

89 studies on the registry are indexed under Conversion Disorder; 34 are open to participants now.

This study's planned enrollment of 216 is above the median of 60 across 37 observational studies indexed under Conversion Disorder.

Browse Conversion Disorder studies →

Lead sponsor

Medical University of Graz is the lead sponsor of 471 studies on the registry; 98 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients with functional and non-functional movement disorders of the Movement Disorders Outpatient Clinic of the Department of Neurology, Medical University of Graz

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Functional or non-functional movement disorder
  • 18 to 80 years

Exclusion criteria

Exclusion Criteria:

  • Patient is not able to consent
  • Patient is not able to understand / speak German fluently (questionnaires are available only in German)
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
216 participants (estimated)
Patient registry
No

Groups and cohorts

  • Parkinson Disease

    Diagnostic Test: Neurological examination · Diagnostic Test: Anamnesis · Diagnostic Test: Neuropsychological testing · Diagnostic Test: Questionnaires · Diagnostic Test: Tremor recording

  • Idiopathic Dystonia

    Diagnostic Test: Neurological examination · Diagnostic Test: Anamnesis · Diagnostic Test: Neuropsychological testing · Diagnostic Test: Questionnaires · Diagnostic Test: Tremor recording

  • Essential Tremor

    Diagnostic Test: Neurological examination · Diagnostic Test: Anamnesis · Diagnostic Test: Neuropsychological testing · Diagnostic Test: Questionnaires · Diagnostic Test: Tremor recording

  • Functional Neurological Disorder

    Diagnostic Test: Neurological examination · Diagnostic Test: Anamnesis · Diagnostic Test: Neuropsychological testing · Diagnostic Test: Questionnaires · Diagnostic Test: Tremor recording

  • Functional Cognitive Disorder

    Diagnostic Test: Neurological examination · Diagnostic Test: Anamnesis · Diagnostic Test: Neuropsychological testing · Diagnostic Test: Questionnaires · Diagnostic Test: Tremor recording

  • Alzheimer Disease

    Diagnostic Test: Neurological examination · Diagnostic Test: Anamnesis · Diagnostic Test: Neuropsychological testing · Diagnostic Test: Questionnaires · Diagnostic Test: Tremor recording

Interventions

  • Diagnostic testNeurological examination

    A neurological examination following a protocol to detect positive signs of functional neurological disorders.

  • Diagnostic testAnamnesis

    A standardized question about the patient´s history. The response time is measured. Question: "Could you tell me about the problems with the movement disorder you are experiencing?"

  • Diagnostic testNeuropsychological testing

    Neuropsychological cognitive testing including: * Montreal Cognitive Assessment (MOCA) * Rey-Osterrieth Complex Figure Test (ROCFT) * Wechsler Memory Scale IV * Comprehensive Trail Making Test (CTMT) * semantic and phonematic fluency tests

  • Diagnostic testQuestionnaires

    * Short Form 36 (SF 36) * Somatic Symptom Disorder - B Criteria Scale (SSD 12) * Patient Health Questionnaire 9 (PHQ 9) * Patient Health Questionnaire 15 (PHQ 15) * Generalized Anxiety Disorder 7 (GAD 7) * Fatigue Severity Scale (FSS) * Psychosomatic Competence Inventory (PSCI) * Work Ability Index (WAI) * Level of Personality Functioning Scale * Toronto Alexithymia Scale * Levels of Emotional Awareness Scale (short version) * Certainty About Mental States Questionnaire * Somatosensoric Amplification Scale * Personality Inventory for DSM-5 short version (PID5BF+M) * Childhood Trauma Questionnaire * European Quality of Life 5 Dimensions 5 Level Version (EQ5D5L)

  • Diagnostic testTremor recording

    Accelerometry following a standardized protocol, using a triaxial accelerometer transducer (Biometrics ACL300, Sensitivity 6 100 mV/G, Biometrics Ltd, UK)

06

What researchers measure

Primary outcomes

  1. Functional neurological symptoms

    Diagnosed by positive signs for functional neurological symptoms, as assessed in the neurological examination

    Time frame: on average 30 minutes

Secondary outcomes

  1. Duration of anamnesis

    Duration in seconds of the response to the question: "Could you tell me about the problems with the movement disorder you are experiencing?"

    Time frame: 1 to 3 minutes

  2. Tremor diagnostic

    Sum score of a electrophysiological test battery for psychogenic tremor, a scale from 0 to 10 with higher numbers indicating a higher probability for functional tremor

    Time frame: up to 20 minutes

  3. Subjective quality of life

    European Quality of Life 5 Dimensions 5 Level Version (EQ 5D 5L), results in a 5-digit number that describes the patient's health state

    Time frame: 5 minutes

  4. Subjective health

    Short Form 36 Questionnaire (SF-36), a 36 items questionnaires that results in 8 scales that describe the subjective health state of the patient, higher values indicating better health

    Time frame: up to 10 minutes

  5. Fatigue

    Fatigue severity scale (FSS): 9 item questionnaire with a 7 point Likert scale, higher values indicating more fatigue

    Time frame: up to 5 minutes

  6. General anxiety

    General anxiety disorder scale 7 (GAD-7): a 7 items questionnaire (0 to 21 points, higher values indicating more anxiety)

    Time frame: 3 minutes

  7. Somatic symptoms

    Patient health questionnaire 15 (PHQ 15): a 15 item questionnaire (0 to 30 points, higher values indicating more somatic symptoms)

    Time frame: 5 minutes

  8. Depression

    Patient health questionnaire 9 (PHQ 9): a 9 item questionnaire (0 to 27 points, higher values indicating more depressive symptoms)

    Time frame: 3 minutes

  9. Psychosomatic Competence

    Psychosomatic Competence Inventory (PSCI): a 44 items questionnaire with a 6 point Likert scale, resulting in 6 subscales, higher values indicate higher psychosomatic competence

    Time frame: up to 10 minutes

  10. Work ability

    Work ability index (WAI): 7 item questionnaire, 7 to 49 points, with higher values indicating better work ability

    Time frame: 5 minutes

  11. Trauma in childhood

    Child Trauma Questionnaire (CTQ): 28 items questionnaire, 5 point Likert scale, resulting in 5 subscales with 5 to 25 points, with higher values indicating more trauma experience

    Time frame: up to 10 minutes

  12. Attachment styles

    Experience of Close Relationships-Revised (ECR-RD 12): 12 items questionnaire with a 7 point Likert scale, resulting in 2 subscales

    Time frame: 5 minutes

  13. Alexithymia

    Toronto alexithymia scale (TAS): 26 items questionnaire with a 5 point Likert scale, higher values indicating more alexithymia

    Time frame: 5 minutes

  14. Personality traits

    The Personality Inventory for DSM-5 and ICD-11 Plus Modified (PID5BF + M): a 36 items questionnaire, with a 4 point Likert scale, resulting in 6 subscales

    Time frame: up to 10 minutes

  15. Personality functioning

    Levels of personality functioning scale (LPFS): a 80 items questionnaire, with a 4 point Likert scale, resulting in 4 subscales

    Time frame: up to 15 minutes

  16. Executive function

    Comprehensive trail making test (CTMT)

    Time frame: up to 10 minutes

  17. Memory

    Wechsler Memory Scale

    Time frame: up to 15 minutes

  18. Visuospatial abilities

    Rey-Osterrieth complex figure test

    Time frame: up to 15 minutes

  19. Functional cognitive symptoms

    Incongruence in cognitive tests

    Time frame: up to 60 minutes

  20. Semantic word fluency

    number of animals that can be listed in 2 minutes

    Time frame: 2 minutes

  21. phonematic word fluency

    number of words, that start with the letter "b", that can be listed in 2 minutes

    Time frame: 2 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2023 (actual). Primary completion is estimated for Dec 2025, 35 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 5, 2023
First posted
Jul 13, 2023
StartActual
Jan 1, 2023
Primary completionEst.
Dec 31, 2025
CompletionEst.
Jun 30, 2026
Last update
Sep 29, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05943652
Responsible party
Sponsor
First posted
Jul 13, 2023
Start date
Jan 1, 2023
Primary completion
Dec 31, 2025 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Sep 29, 2025

Study contacts

Daniela Kern, MD
Contact
daniela.eibl@medunigraz.at
004331638516051
Petra Schwingenschuh, MD
Contact
petra.schwingenschuh@medunigraz.at
004331638583379

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion